1.1400
-0.1100
(-8.80%)
As of 12:45:31 PM EDT. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. John Michael Climaco Esq., J.D. | CEO, President & Director | 525k | -- | 1969 |
| Mr. Christopher S. Downs CPA, CTP, FP&A | Chief Financial Officer | 382.16k | -- | 1978 |
| Dr. Sandra L. Silberman M.D., Ph.D. | Chief Medical Officer | 261.2k | -- | 1955 |
| Dr. Waldemar Priebe Ph.D. | Founder | -- | -- | -- |
| Dr. Donald H. Picker Ph.D. | Chief Science Officer | -- | -- | 1946 |
CNS Pharmaceuticals, Inc.
2100 West Loop South
Suite 900
Houston, TX 77027
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 3
Description
CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. CNS Pharmaceuticals, Inc. has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as a collaboration and asset purchase agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.
Corporate Governance
CNS Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 13, 2025 at 8:00 PM UTC - May 19, 2025 at 8:00 PM UTC
CNS Pharmaceuticals, Inc. Earnings Date
Recent Events
Related Tickers
CERO CERo Therapeutics Holdings, Inc.
0.7090
-2.74%
CDIO Cardio Diagnostics Holdings, Inc.
0.3275
-5.04%
VRPX Virpax Pharmaceuticals, Inc.
0.5076
-58.37%
ADTX Aditxt, Inc.
5.25
+5.01%
AEON AEON Biopharma, Inc.
0.5200
-3.81%
ALLR Allarity Therapeutics, Inc.
0.8369
-5.27%
MBRX Moleculin Biotech, Inc.
0.8780
-8.57%
HOTH Hoth Therapeutics, Inc.
0.9363
-4.30%
RNAZ TransCode Therapeutics, Inc.
0.4910
-7.09%
GNPX Genprex, Inc.
0.3917
+32.78%